JGO Reading Tools
How to cite item
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{JGO}{73708}, author = {Takahashi, S., Ouchi, K., Sakamoto, Y., Mori, T., Shimodaira, H., Takahashi, M., Ohori, H., Kudo, C., Takahashi, Y., Imai, H., Akiyama, S., Takahashi, M., Suto, T., Murakawa, Y., Oishi, T., Isobe, H., Okada, Y., Kawai, S., Yoshioka, T., Sato, T., Shindo, Y., Sugiyama, S., Komine, K., Chiba, N., Okita, A., Yamaguchi, T., Ishioka, C.}, title = {Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201}, journal = {Journal of Gastrointestinal Oncology}, volume = {14}, number = {2}, year = {2023}, url = {https://jgo.amegroups.org/article/view/73708} }